Lupus and Your Organs: Kidneys and the Brain
Last updated:
Systemic lupus can severely affect major organs, most commonly causing Lupus Nephritis in the kidneys and Neuropsychiatric SLE in the brain. Regular screening is crucial because early organ involvement often occurs before noticeable symptoms like foamy urine, swelling, or brain fog appear.
Key Takeaways
- • Lupus Nephritis affects up to 50% of people with SLE and requires regular urine testing to catch early.
- • A kidney biopsy is the gold standard for identifying the severity of lupus nephritis and guiding treatment decisions.
- • Class IV lupus nephritis is the most common and severe form, requiring intensive treatment to prevent long-term scarring.
- • Neuropsychiatric SLE can cause cognitive dysfunction known as lupus fog, alongside mood disorders, seizures, and stroke.
- • Brain MRIs are utilized to detect lupus-related inflammation and lesions within the central nervous system.
While lupus can affect almost any part of the body, it behaves differently depending on which organs are involved. Two of the most serious ways lupus can manifest are through the kidneys (Lupus Nephritis) and the central nervous system (Neuropsychiatric Lupus). Understanding these patterns helps you and your doctor stay ahead of the disease.
Lupus Nephritis: Protecting Your Kidneys
Lupus Nephritis (LN) occurs when lupus autoantibodies attack the filters in your kidneys [1]. It affects up to 50% of people with SLE and often has no symptoms in its early stages, which is why regular urine tests are vital [2]. As it progresses, physical warning signs can include foamy urine (a sign of protein spilling into the urine) or sudden swelling in your legs, ankles, and feet.
To understand the extent of the damage, doctors use the ISN/RPS Classification system (Classes I–VI) based on a kidney biopsy [3]:
- Why a Biopsy?: A biopsy is the “gold standard” because blood and urine tests don’t always show the full picture of what is happening inside the kidney tissue [4][5].
- Class IV (Diffuse Segmental/Global): This is the most common and most severe form. It involves active, widespread inflammation and requires intensive treatment to prevent long-term scarring [2][4].
- Activity vs. Chronicity: Your biopsy report will show an Activity Index (current, reversible inflammation) and a Chronicity Index (permanent scarring) [6][3]. High activity scores mean your treatment needs to be more aggressive to stop the damage [6].
Neuropsychiatric SLE (NPSLE): The “Brain Fog” and Beyond
When lupus involves the brain or nervous system, it is called Neuropsychiatric SLE (NPSLE). This can manifest in several ways [7]:
- Cognitive Dysfunction: Often called “lupus fog,” this includes trouble with memory, concentration, and word-finding. It is the most common symptom, affecting up to 38-46% of patients [8][7]. Practical coping strategies can make a big difference: try keeping a daily symptom journal, taking photos of where you leave items, or using pacing techniques to manage your mental energy.
- Mood Disorders: Significant depression or anxiety can be a direct result of lupus-related inflammation in the brain [9][10].
- Seizures and Stroke: While less common, these are serious manifestations that occur when inflammation or blood clots affect brain function [11][12].
- Diagnosis: Doctors often use an MRI to look for small lesions or changes in brain volume that indicate lupus activity [13][8].
Frequently Asked Questions
What are the early physical signs of lupus nephritis?
Why is a kidney biopsy required if I have lupus?
What do the activity and chronicity scores mean on my kidney biopsy?
What is lupus brain fog?
How do doctors test for neuropsychiatric lupus?
Questions for Your Doctor
- • If my proteinuria is above 500 mg, should we be scheduling a kidney biopsy now to check for lupus nephritis?
- • Based on my biopsy, what is my ISN/RPS Class, and what are my 'activity' and 'chronicity' scores?
- • Since Class IV is the most aggressive form, how will our treatment plan differ if that is my diagnosis?
- • Could my 'brain fog' or recent mood changes be related to NPSLE, and should we consider a brain MRI or testing for anti-ribosomal P antibodies?
- • For my child with cSLE, how will we monitor for and minimize the long-term effects of steroid treatments, like impacts on bone density?
Questions for You
- • Have I noticed any physical signs of kidney issues, such as foamy urine or swelling in my ankles and feet?
- • Am I experiencing new or worsening 'cognitive dysfunction,' such as trouble finding words, remembering appointments, or concentrating at work?
- • If I am a parent of a child with lupus, have I noticed changes in their school performance or mood that could be a sign of CNS involvement?
- • How am I tracking my daily symptoms to help my doctor distinguish between general lupus fatigue and specific organ-related issues?
Want personalized information?
Type your question below to get evidence-based answers tailored to your situation.
References
- 1
Anti-double Stranded DNA Antibodies: Origin, Pathogenicity, and Targeted Therapies.
Wang X, Xia Y
Frontiers in immunology 2019; (10()):1667 doi:10.3389/fimmu.2019.01667.
PMID: 31379858 - 2
Clinicopathological correlation in lupus nephritis: a 5-year tertiary center experience using International Society of Nephrology/Renal Pathology Society classification.
Rangachari B, Sasidharannair Chandrakumari A, Rao L, et al.
Annals of medicine and surgery (2012) 2026; (88(3)):2282-2287 doi:10.1097/MS9.0000000000004787.
PMID: 41789237 - 3
Morphological Indexes: Can They Predict Lupus Nephritis Outcomes? A Retrospective Study.
Navarro D, Ferreira AC, Viana H, et al.
Acta medica portuguesa 2019; (32(10)):635-640 doi:10.20344/amp.11598.
PMID: 31625875 - 4
A clinico-pathological study of lupus nephritis based on the International Society of Nephrology-Renal Pathology Society 2003 classification system.
Satish S, Deka P, Shetty MS
Journal of laboratory physicians 2017; (9(3)):149-155 doi:10.4103/JLP.JLP_44_16.
PMID: 28706383 - 5
Redefining lupus nephritis: clinical implications of pathophysiologic subtypes.
Yu F, Haas M, Glassock R, Zhao MH
Nature reviews. Nephrology 2017; (13(8)):483-495 doi:10.1038/nrneph.2017.85.
PMID: 28669995 - 6
A Validation of the 2018 Revision of International Society of Nephrology/Renal Pathology Society Classification for Lupus Nephritis: A Cohort Study from China.
Tao J, Wang H, Yu XJ, et al.
American journal of nephrology 2020; (51(6)):483-492 doi:10.1159/000507213.
PMID: 32320985 - 7
Neuropsychiatric Systemic Lupus Erythematosus: A Systematic Review.
Rice-Canetto TE, Joshi SJ, Kyan KA, Siddiqi J
Cureus 2024; (16(6)):e61678 doi:10.7759/cureus.61678.
PMID: 38975440 - 8
Clinical Factors Associated with Brain Volume Reduction in Systemic Lupus Erythematosus Patients without Major Neuropsychiatric Manifestations.
Liu S, Cheng Y, Zhao Y, et al.
Frontiers in psychiatry 2018; (9()):8 doi:10.3389/fpsyt.2018.00008.
PMID: 29449817 - 9
Neuropsychiatric Manifestations in Systemic Lupus Erythematosus Patients at a Tertiary Hospital in Peru.
Camones-Huerta J, Arias-Osorio C, Rodriguez-Hurtado D, Aguilar-Olano J
European journal of rheumatology 2023; (10(4)):143-147 doi:10.5152/eurjrheum.2023.22095.
PMID: 37850607 - 10
[Neurocognitive Disorders Caused by Central Nervous System Lupus Erythematosus].
Nishimura K
Brain and nerve = Shinkei kenkyu no shinpo 2016; (68(4)):365-73 doi:10.11477/mf.1416200406.
PMID: 27056854 - 11
The Discrepancy of ANA and Compartment Bead Patterns Suggestive of a Neuropsychiatry Systemic Lupus Erythematosus (NPSLE).
Fitriah M, Rahmawati LD, Wulanda IA, et al.
Case reports in psychiatry 2023; (2023()):5260208 doi:10.1155/2023/5260208.
PMID: 37928319 - 12
Cognitive and White Matter Tract Differences in MS and Diffuse Neuropsychiatric Systemic Lupus Erythematosus.
Cesar B, Dwyer MG, Shucard JL, et al.
AJNR. American journal of neuroradiology 2015; (36(10)):1874-83 doi:10.3174/ajnr.A4354.
PMID: 26066628 - 13
Central neurological manifestations in a sample of Syrian patients with systemic lupus erythematosus: cross-sectional study.
Kudsi M, Achmeh B, Khalayli N, et al.
Annals of medicine and surgery (2012) 2024; (86(9)):5096-5100 doi:10.1097/MS9.0000000000002361.
PMID: 39238971
This page explains lupus organ involvement for educational purposes only and does not constitute medical advice. Always consult your rheumatologist, nephrologist, or neurologist regarding specific symptoms or treatment plans.
Stay up to date
Get notified when new research about Systemic lupus erythematosus is published.
No spam. Unsubscribe anytime.